AGC Pharma Chemicals: Recognized as the Best Manufacturing Capabilities at the CDMO Leadership Awards 2025

21 March 2025

The company has received the award in the "Best Manufacturing Capabilities" category, recognizing its expertise and quality in pharmaceutical manufacturing.
This prestigious international recognition is based on customer evaluations across multiple categories.

Barcelona, March 24, 2025 – AGC Pharma Chemicals, a global CDMO specializing in Active Pharmaceutical Ingredients (APIs) and intermediates, with facilities in Spain (Barcelona) and Japan, has been honored with the prestigious CDMO Leadership Award at the 2025 Outsourced Pharma Awards in the "Best Manufacturing Capabilities" category. Presented by Outsourced Pharma and Life Science Connect, this award highlights AGC Pharma Chemicals' excellence in API manufacturing and its commitment to innovation and quality in the industry.

Akihiro Kadokura, CEO of AGC Pharma Chemicals

The CDMO Leadership Award is based on independent surveys conducted among leaders in the biopharmaceutical and biotechnology industries, who evaluate contract development and manufacturing organizations (CDMOs) on key criteria such as facilities, scientific expertise, manufacturing capabilities, and quality management. Winning this award underscores AGC Pharma Chemicals' ability to meet the highest industry standards and its dedication to providing innovative and tailored solutions for its clients.

Akihiro Kadokura, CEO of AGC Pharma Chemicals, stated: "We are deeply honored to receive this prestigious recognition. Customer satisfaction and success have always been our top priorities, and this award validates our efforts and dedication. We sincerely thank our clients for their trust and continuous support, as they are the ones who have rated us the best in this category".

The company has distinguished itself in the industry through strategic investments in cutting-edge technology, continuous process improvement, and a highly skilled team. This recognition further strengthens AGC Pharma Chemicals’ position as a key partner in the global pharmaceutical industry, reaffirming its mission to deliver high-quality solutions that meet customer needs and drive industry advancements. Additionally, at the event, AGC Biologics was also honored with the award for "Best Quality Management Systems".

About AGC Pharma Chemicals
With locations in Spain and Japan, AGC Pharma Chemicals is an innovative contract development and manufacturing organization (CDMO) dedicated to the global pharmaceutical industry. The company specializes in the development and production of active pharmaceutical ingredients (APIs) and their intermediates. As part of the AGC Group, AGC Pharma Chemicals benefits from solid business growth and financial stability. The AGC Group is a global conglomerate with more than 190 companies, 56,700 employees, and a presence in over 30 countries. In 2023, it achieved net sales of 13,286 million euros.

For more information or interviews, please contact:

AGC Pharma Chemicals
Guillermina Riva Carretti guillerminarivac@gmail.com
Teléfono: +34 680 534 459

TEAM LEWIS
Mauro Tomasini/Marta Subiranas
agcpharma@teamlewis.com
Teléfono: +34 93 522 86 27